Scilex Holding Reported Earnings

Scilex Holding (SCLX) reported a loss of $16.65 per share on revenue of $7.64 million for the . . Revenue fell 22.78% compared to the same quarter a year ago.

Scilex Holding Company is a commercial biopharmaceutical company focused on developing and commercializing non-opioid therapies for patients with acute and chronic pain. Scilex Holding Company, formerly known as Vickers Vantage Corp. I, is based in PALO ALTO, Calif.